- Home
- SCPH vs AMRN Comparison
SCPH vs AMRN Comparison
Compare SCPH & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- AMRN
- Stock Information
- Founded
- SCPH 2013
- AMRN 1989
- Country
- SCPH United States
- AMRN Ireland
- Employees
- SCPH N/A
- AMRN N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- SCPH Health Care
- AMRN Health Care
- Exchange
- SCPH Nasdaq
- AMRN Nasdaq
- Market Cap
- SCPH 173.6M
- AMRN 189.2M
- IPO Year
- SCPH 2017
- AMRN 1993
- Fundamental
- Price
- SCPH $2.57
- AMRN $9.11
- Analyst Decision
- SCPH Strong Buy
- AMRN Sell
- Analyst Count
- SCPH 3
- AMRN 2
- Target Price
- SCPH $14.00
- AMRN $7.00
- AVG Volume (30 Days)
- SCPH 519.0K
- AMRN 103.6K
- Earning Date
- SCPH 05-13-2025
- AMRN 04-30-2025
- Dividend Yield
- SCPH N/A
- AMRN N/A
- EPS Growth
- SCPH N/A
- AMRN N/A
- EPS
- SCPH N/A
- AMRN N/A
- Revenue
- SCPH $36,332,000.00
- AMRN $228,614,000.00
- Revenue This Year
- SCPH $114.00
- AMRN N/A
- Revenue Next Year
- SCPH $77.45
- AMRN $5.18
- P/E Ratio
- SCPH N/A
- AMRN N/A
- Revenue Growth
- SCPH 167.28
- AMRN N/A
- 52 Week Low
- SCPH $1.94
- AMRN $7.00
- 52 Week High
- SCPH $5.65
- AMRN $20.60
- Technical
- Relative Strength Index (RSI)
- SCPH 47.35
- AMRN 48.45
- Support Level
- SCPH $1.94
- AMRN $8.32
- Resistance Level
- SCPH $2.71
- AMRN $10.06
- Average True Range (ATR)
- SCPH 0.27
- AMRN 0.87
- MACD
- SCPH 0.04
- AMRN 0.15
- Stochastic Oscillator
- SCPH 76.36
- AMRN 60.40
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.